EGFR Exon 20 (Insertion)
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | EGFR Exon 20 (Insertion) | Non-Small Cell Lung Cancer | Amivantamab, Carboplatin, Pemetrexed | |
| EMA (1) FDA (2) | EGFR Exon 20 (Insertion) | Non-Small Cell Lung Cancer | Amivantamab | |
| FDA (2) | EGFR Exon 20 (Insertion) | Non-Small Cell Lung Cancer | Mobocertinib | |
| FDA (2) | EGFR Exon 20 (Insertion) | Invasive Breast Carcinoma | Datopotamab deruxtecan | |
| FDA (2) | EGFR Exon 20 (Insertion) | Non-Small Cell Lung Cancer | Sunvozertinib |